Similar articles for PMID: 26165399

Year	Number of Results
1995	2
1996	1
1999	1
2000	1
2001	1
2002	1
2003	2
2005	1
2006	4
2007	3
2008	5
2009	5
2010	1
2011	2
2012	6
2013	10
2014	5
2015	9
2016	8
2017	11
2018	12
2019	5
2020	8
2021	12
2022	3
2024	0

1

Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1.

Yates CJ, Newey PJ, Thakker RV. Yates CJ, et al. Lancet Diabetes Endocrinol. 2015 Nov;3(11):895-905. doi: 10.1016/S2213-8587(15)00043-1. Epub 2015 Jul 9. Lancet Diabetes Endocrinol. 2015. PMID: 26165399 Review.

2

Complicated Case Presentation: Management of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.

Mulvey CK, Van Loon K, Bergsland EK, Masharani U, Nakakura EK. Mulvey CK, et al. Pancreas. 2017 Mar;46(3):416-426. doi: 10.1097/MPA.0000000000000770. Pancreas. 2017. PMID: 28187108 Review.

3

What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?

Challis BG, Casey RT, Grossman A, Newell-Price J, Newey P, Thakker RV. Challis BG, et al. Clin Endocrinol (Oxf). 2019 Dec;91(6):708-715. doi: 10.1111/cen.14094. Epub 2019 Oct 1. Clin Endocrinol (Oxf). 2019. PMID: 31505044 Review.

4

Current and emerging therapies for PNETs in patients with or without MEN1.

Frost M, Lines KE, Thakker RV. Frost M, et al. Nat Rev Endocrinol. 2018 Apr;14(4):216-227. doi: 10.1038/nrendo.2018.3. Epub 2018 Feb 16. Nat Rev Endocrinol. 2018. PMID: 29449689 Free PMC article. Review.

5

Clinical aspects of multiple endocrine neoplasia type 1.

Al-Salameh A, Cadiot G, Calender A, Goudet P, Chanson P. Al-Salameh A, et al. Nat Rev Endocrinol. 2021 Apr;17(4):207-224. doi: 10.1038/s41574-021-00468-3. Epub 2021 Feb 9. Nat Rev Endocrinol. 2021. PMID: 33564173 Review.

6

Pancreatic neuroendocrine tumours.

Alexakis N, Neoptolemos JP. Alexakis N, et al. Best Pract Res Clin Gastroenterol. 2008;22(1):183-205. doi: 10.1016/j.bpg.2007.10.008. Best Pract Res Clin Gastroenterol. 2008. PMID: 18206821 Review.

7

Multiple endocrine neoplasia type 1.

Marini F, Falchetti A, Del Monte F, Carbonell Sala S, Gozzini A, Luzi E, Brandi ML. Marini F, et al. Orphanet J Rare Dis. 2006 Oct 2;1:38. doi: 10.1186/1750-1172-1-38. Orphanet J Rare Dis. 2006. PMID: 17014705 Free PMC article. Review.

8

Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.

Sala E, Ferrante E, Verrua E, Malchiodi E, Mantovani G, Filopanti M, Ferrero S, Pietrabissa A, Vanoli A, La Rosa S, Zatelli MC, Beck-Peccoz P, Verga U. Sala E, et al. Eur J Gastroenterol Hepatol. 2013 Jul;25(7):858-62. doi: 10.1097/MEG.0b013e32835f433f. Eur J Gastroenterol Hepatol. 2013. PMID: 23542451

9

Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.

Jensen RT, Norton JA. Jensen RT, et al. Pancreas. 2017 May/Jun;46(5):589-594. doi: 10.1097/MPA.0000000000000825. Pancreas. 2017. PMID: 28426491 Free PMC article. No abstract available.

10

Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient.

Jullien M, Reichert T, D'Anella P, Castinetti F, Barlier A, Brue T, Taieb D, Cuny T. Jullien M, et al. Ann Endocrinol (Paris). 2020 Feb;81(1):39-43. doi: 10.1016/j.ando.2019.11.001. Epub 2019 Dec 16. Ann Endocrinol (Paris). 2020. PMID: 31982106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

102 results

Results by year